NATIONWIDE POPULATION-LEVEL REAL-WORLD EVIDENCE OF LONG-TERM MORTALITY, LIVER AND NON-LIVER BENEFITS OF DAA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS (CHC) TREATED WITH DIRECT-ACTING ANTIVIRALS (DAA) Ogawa, E., Chien, N., Kam, L., Tran, S., Huang, D., Yeo, Y., Ji, F., Henry, L., Cheung, R., Nguyen, M. H. WILEY. 2022: S373-S374

View details for Web of Science ID 000870796601105